Open access · CC-BY
via OpenAlex
Suppression of Th17-polarized airway inflammation by rapamycin
Oana Joean, Anja Hueber, Felix Feller, Adan Chari Jirmo, Matthias Lochner, Anna‐Maria Dittrich, Melanie Albrecht
Scientific Reports · 2017 · ▲ 14 citations
Abstract
Because Th17-polarized airway inflammation correlates with poor control in bronchial asthma and is a feature of numerous other difficult-to-treat inflammatory lung diseases, new therapeutic approaches for this type of airway inflammation are necessary. We assessed different licensed anti-inflammatory agents with known or expected efficacy against Th17-polarization in mouse models of Th17-dependent airway inflammation. Upon intravenous transfer of in vitro derived Th17 cells and intranasal challenge with the corresponding antigen, we established acute and chronic murine models of Th17-polarised airway inflammation. Consecutively, we assessed the efficacy of methylprednisolone, roflumilast, azithromycin, AM80 and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) against acute or chronic Th17-dependent airway inflammation. Quantifiers for Th17-associated inflammation comprised: bronchoalveolar lavage (BAL) differential cell counts, allergen-specific cytokine and immunoglobulin secretion, as well as flow cytometric phenotyping of pulmonary inflammatory cells. Only rapamycin proved effective against acute Th17-dependent airway inflammation, accompanied by increased plasmacytoid dendritic cells (pDCs) and reduced neutrophils as well as reduced CXCL-1 levels in BAL. Chronic Th17-dependent airway inflammation was unaltered by rapamycin treatment. None of the other agents showed efficacy in our models. Our results demonstrate that Th17-dependent airway inflammation is difficult to treat with known agents. However, we identify rapamycin as an agent with inhibitory potential against acute Th17-polarized airway inflammation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-017-15750-6
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Joean, O., Hueber, A., Feller, F., Jirmo, A.C., Lochner, M., Dittrich, A., & Albrecht, M. (2017). Suppression of Th17-polarized airway inflammation by rapamycin. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-017-15750-6
Vancouver
Joean O, Hueber A, Feller F, Jirmo AC, Lochner M, Dittrich A, et al. Suppression of Th17-polarized airway inflammation by rapamycin. Scientific Reports. 2017. doi:10.1038/s41598-017-15750-6.
BibTeX
@article{oana2017Suppre,
title = {Suppression of Th17-polarized airway inflammation by rapamycin},
author = {Oana Joean and Anja Hueber and Felix Feller and Adan Chari Jirmo and Matthias Lochner and Anna‐Maria Dittrich and Melanie Albrecht},
journal = {Scientific Reports},
year = {2017},
doi = {10.1038/s41598-017-15750-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Reviews and Reports 2025
Open access · CC-BY
Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents
Stem cell reviews and reports 2025
Open access · OA
Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents.
Cell Death and Differentiation 2014
Preprint · OA
Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · OA
Decay in Transcriptional Information Flow Is a Hallmark of Cellular Aging
Aging Cell 2012
Preprint · OA
Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Journal of cachexia, sarcopenia and muscle 2026
Citation only